OTL-200

pharma-news-for-bms-orchard-madrigal-astrazeneca

Mar 19, 2024

Bristol Myers Squibb’ Karuna Therapeutics Buyout; Orchard Therapeutics’ Lenmeldy FDA Approval; Madrigal Pharmaceuticals’ Rezdiffra FDA Approval; AstraZeneca’s Acquisition of Amolyt Pharma; Prilenia’s Pridopidine EU Marketing Approval

orchards-otl-200-for-metachromatic-leukodystrophy-treatment

Sep 25, 2023

Orchard’s OTL-200 to Enter US Metachromatic Leukodystrophy Treatment Space After EU

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper